DHT Stanolone Basic Chemical Info :
CAS No : 521-18-6
Molecular Formula: C19H30O2
Molecular Weight: 290.44
EINECS No: 208-307-3
Melting Point: 176.5-181 °C
What is Stanolone DHT ?
Dihydrotestosterone (DHT), or 5α-dihydrotestosterone (5α-DHT), also known as 5α-androstan-17β-ol-3-one, is an endogenous androgen sex steroid and hormone. The enzyme 5α-reductase catalyzes the formation of DHT from testosterone in certain tissues including the prostate gland, seminal vesicles, epididymides, skin, hair follicles, liver, and brain. This enzyme mediates reduction of the C4-5 double bond of testosterone. Relative to testosterone, DHT is considerably more potent as an agonist of the androgen receptor.
Andractim DHT is a non-aromatizing androgen, which as you know, means it doesnt convert to estrogen at all. This is important because estrogen is suppressive of LH production, which is of course going to be an aggravating factor in lowering your endogenous testosterone production. Andractim DHT, in addition to not converting to that nasty test-suppressive-estrogen, will not inhibit LH production or testosterone production. Andractim DHT may even have a suppressive effect on estrogen, in some cases. This would certainly account for its ability to actually have a positive effect (again, in some cases) on LH and testosterone.
Stanolone DHT Uses
Andractim has been used with some success to reduce gyno in males. Its possible that a lowering of circulating DHT-levels can cause Gyno, and certainly androgen therapy with DHT derivatives has been found useful for treatment of gyno… so its very logical that a topical DHT would be a good beat for Anabolic/Androgenic Steroid induced Gyno.
Stanolone DHT Application
DHT is available in pharmaceutical formulations for medical use as an androgen or anabolic-androgenic steroid (AAS). When used as a drug, it is referred to as androstanolone or as stanolone. The availability of pharmaceutical DHT is limited; it is not available in the United States or Canada, but is available in certain European countries, including the United Kingdom, Germany, France, Spain, Italy, Belgium, and Luxembourg. Brand names of DHT include Anaboleen, Anabolex, Anaprotin (UK), Andractim (formerly AndroGel-DHT) (FR, BE, LU), Androlone, Apeton, Gelovit (ES), Neodrol, Ophtovital, (DE), Pesomax (IT), Stanaprol, and Stanolone, among others. The available formulations of DHT include buccal or sublingual tablets (Anabolex, Stanolone), topical gels (Andractim, Gelovit, Ophtovital), and, as esters in oil, injectables like dihydrotestosterone propionate (Pesomax) and dihydrotestosterone valerate (Apeton). Esters of DHT act as prodrugs of DHT in the body and have a long-lasting depot when given via intramuscular injection. Dihydrotestosterone benzoate (Ermalone-Amp, Hermalone, Sarcosan) and dihydrotestosterone enanthate (Anaboleen Depot) are additional DHT esters that are also available for medical use, while a few others, including dihydrotestosterone acetate, dihydrotestosterone butyrate, and dihydrotestosterone formate, were developed but never marketed.
Pharmaceutical DHT is used mainly in the treatment of male hypogonadism. It was under development in a topical formulation for the treatment of cachexia in cancer patients, and reached phase III clinical trials for this indication, but ultimately was not introduced for this purpose. Although DHT itself has not been approved for the treatment of cachexia, an orally active synthetic derivative of DHT, oxandrolone (2-oxa-17α-methyl-DHT), is approved and used for this indication.
